.svg){kind=small}
We are pleased to announce that our abstract has been selected for an oral presentation at APASL 2024. The Asia-Pacific Association for the Study of Liver (APASL) Congress is an important event in the field of hepatology, bringing together experts from around the globe to discuss the latest advancements, research findings, and clinical insights.
Our presentation promises to contribute valuable insights to the conference program. We are honoured to have this platform to share our research and engage with fellow professionals in the field.
To find out more: https://www.apasl2024kyoto.org/
-min.jpg)
.jpg)
Latest news
Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations
April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read moreAnnouncement of Jorg Becoming President Elect
April 22, 2024
Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.
Read moreEvents
AHA Hypertension Scientific Sessions 2024
5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event
